L. Perrigo Recalls Scopolamine Transdermal System Due to Defective Delivery System
L. Perrigo is recalling 569,520 cartons of Scopolamine Transdermal System nationwide due to a defective delivery system.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity level where the product may cause temporary or medically reversible adverse health consequences, but no serious injury or death is reported.
Plain-English summary
L. Perrigo Company is recalling 569,520 cartons of Scopolamine Transdermal System, 1 mg/3 days, in 4-count, 10-count, and 24-count packages. The product is distributed nationwide in the U.S.A. and is manufactured by Aveva Drug Delivery Systems, a Nitto Denko Company, and distributed by Perrigo.
The recall is being conducted due to a defective delivery system. The affected lots include specific expiration dates ranging from March 2019 to October 2019, as detailed in the recall notice.
Consumers should stop using the recalled product and contact their healthcare provider or pharmacist for further instructions. The recall is classified as FDA Class II, indicating a reasonable probability that use of the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- SCOPOLAMINE TRANSDERMAL SYSTEM (SCOPOLAMINE TRANSDERMAL SYSTEM)
- Brand
- SCOPOLAMINE TRANSDERMAL SYSTEM
- Manufacturer
- L. Perrigo Company
- Category
- Drug — Transdermal Patch
- Affected units
- 569,520
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: a) 46397
- 46457 Exp 03/19
- 46621
- Exp 04/19
- 46894
- 46904
- 46905
- Exp 06/19
- 47133
- Exp 07/19
- 47153
- Exp 08/19
- 47154
- 47213
- 47214
- Exp 09/19
- b) 46695
- 46994
- 47012
- 47322 10/19
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · L. Perrigo Company
See all →- HighBASIC CARE Allergy Tablets Recalled Due to Failed Quality Specifications
FDA (Drugs) · 2023-07-19
- HighFexofenadine Hydrochloride Tablets Recalled for Failed Purity Specifications
FDA (Drugs) · 2023-07-19
- HighAllergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2023-07-19
- HighCareone Allergy Relief tablets recalled for failed impurity and degradation specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Allergy Relief Tablets Recalled for Failed Manufacturing Specifications
FDA (Drugs) · 2023-07-19
Same hazard · defective delivery system
See all →- ModerateCetrorelix injection kits recalled over missing or duplicated needles inside
FDA (Drugs) · 2026-02-18
- HighAIRSUPRA Albuterol and Budesonide Inhalation Aerosol Recalled for Defective Delivery System
FDA (Drugs) · 2025-05-28
- HighLorazepam Oral Syringes Recalled Due to Defective Delivery System Causing Leakage
FDA (Drugs) · 2025-03-12
- ModerateVarithena Administration Pack Recalled Due to Incorrect Syringe Connector Type
FDA (Drugs) · 2024-12-18
- HighDaytrana Methylphenidate Transdermal Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29